The FDA and the Cardiovascular Community.
Publication
, Journal Article
Warraich, HJ; Califf, RM
Published in: J Am Coll Cardiol
July 2, 2024
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 2, 2024
Volume
84
Issue
1
Start / End Page
124 / 129
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Warraich, H. J., & Califf, R. M. (2024). The FDA and the Cardiovascular Community. J Am Coll Cardiol, 84(1), 124–129. https://doi.org/10.1016/j.jacc.2024.05.013
Warraich, Haider J., and Robert M. Califf. “The FDA and the Cardiovascular Community.” J Am Coll Cardiol 84, no. 1 (July 2, 2024): 124–29. https://doi.org/10.1016/j.jacc.2024.05.013.
Warraich HJ, Califf RM. The FDA and the Cardiovascular Community. J Am Coll Cardiol. 2024 Jul 2;84(1):124–9.
Warraich, Haider J., and Robert M. Califf. “The FDA and the Cardiovascular Community.” J Am Coll Cardiol, vol. 84, no. 1, July 2024, pp. 124–29. Pubmed, doi:10.1016/j.jacc.2024.05.013.
Warraich HJ, Califf RM. The FDA and the Cardiovascular Community. J Am Coll Cardiol. 2024 Jul 2;84(1):124–129.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 2, 2024
Volume
84
Issue
1
Start / End Page
124 / 129
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology